These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4525942)

  • 21. Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.
    Suciu S; Marinca E; Bornuz F; Crisan M; Petrov L; Rădulescu E
    Blut; 1984 Oct; 49(4):325-30. PubMed ID: 6593103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic studies in basophilic chronic myelocytic leukemia.
    Goh KO; Anderson FW
    Arch Pathol Lab Med; 1979 Jun; 103(6):288-90. PubMed ID: 287415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 9/11 translocation in a child with Ph1-negative chronic myelogenous leukemia.
    Warburton D; Shah N
    J Pediatr; 1976 Apr; 88(4 Pt 1):599-601. PubMed ID: 1062545
    [No Abstract]   [Full Text] [Related]  

  • 24. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia.
    Mintz U; Vardiman J; Golomb HM; Rowley JD
    Cancer; 1979 Feb; 43(2):411-6. PubMed ID: 283874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques.
    Hossfeld DK
    Humangenetik; 1974 Jul; 23(2):111-8. PubMed ID: 4136793
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Philadelphia chromosome (Ph1) translocation in an apparently Ph1 negative, minus G22, case of chronic myeloid leukemia.
    Engel E; McGee BJ; Flexner JM; Russell MT; Myers BJ
    N Engl J Med; 1974 Jul; 291(3):154. PubMed ID: 4525414
    [No Abstract]   [Full Text] [Related]  

  • 27. The karyotype evolution in chronic granulocytic leukaemia--I. The chromosomes gained and lost during initiation of the evolution.
    Pedersen B
    Eur J Cancer (1965); 1973 Jul; 9(7):503-7. PubMed ID: 4529733
    [No Abstract]   [Full Text] [Related]  

  • 28. Structural rearrangements associated with the Ph1 chromosome in chronic granulocytic leukaemia.
    Potter AM; Sharp JC; Brown MJ; Sokol RJ
    Humangenetik; 1975 Sep; 29(3):223-8. PubMed ID: 1058170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemia.
    Kolitz JE; Schulman P; Kardon N; Budman DR; Vinciguerra VP; Broekman A; Degnan TJ
    Cancer Genet Cytogenet; 1981 Oct; 4(2):185-8. PubMed ID: 6949631
    [No Abstract]   [Full Text] [Related]  

  • 30. Ph1-positive leukaemia, including chronic myelogenous leukaemia.
    Rowley JD
    Clin Haematol; 1980 Feb; 9(1):55-86. PubMed ID: 6245823
    [No Abstract]   [Full Text] [Related]  

  • 31. Clonal evolution of karyotype in blastic phase of CML.
    Izakovic V; Horák I; Krizan P
    Neoplasma; 1982; 29(5):613-23. PubMed ID: 6960260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out-of-phase separation of a G-group chromosome in a woman with chronic myelogenous leukemia.
    Vig BK
    Cancer Genet Cytogenet; 1984 Jun; 12(2):167-9. PubMed ID: 6586281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G banding in cytogenetic study of hemoblastoses.
    Fleischman EW; Prigogina EL
    Humangenetik; 1975; 26(4):335-42. PubMed ID: 1056893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytogenetic findings in chronic myelogenous leukemia].
    Prösch U; Stobbe H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):495-514. PubMed ID: 2414179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia-chromosome positive bone-marrow cells showing loss of the Y in males with chronic myeloid leukaemia.
    Lawler SD; Lobb DS; Wiltshaw E
    Br J Haematol; 1974 Jun; 27(2):247-52. PubMed ID: 4527063
    [No Abstract]   [Full Text] [Related]  

  • 36. Coexistence of cells with unmasked and masked Ph1 in a case of chronic myeloid leukemia in blastic phase.
    Pedersen B
    Cancer Genet Cytogenet; 1984 Jun; 12(2):129-37. PubMed ID: 6586280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Masked" Ph1 chromosome abnormalities in CML: a report of two unique cases.
    Bernstein R; Pinto MR; Rosendorff J; Kramer S; Mendelow B
    Blood; 1984 Feb; 63(2):399-406. PubMed ID: 6581842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ph1 and C group marker in a acute leukemia associated with noramidopyrine treatment (author's transl)].
    Moraine C; Brémond JL; Despert F; Leroy J; Leroux ME; Maillet M
    Nouv Rev Fr Hematol; 1974; 14(4):461-70. PubMed ID: 4280556
    [No Abstract]   [Full Text] [Related]  

  • 39. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of reverse banding in detecting bone marrow chromosomal abnormalities: translocation between chromosomes 1, 9, and 22 in a case of chronic myelogenous leukemia (CML).
    Verma RS; Dosik H
    Am J Hematol; 1977; 3():171-5. PubMed ID: 272121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.